Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Longerwait totally underestimates the grounds on which the case will be fought. The LU application was submitted April 21. The reason? A disvovery had been made but further work was needed that would extend beyond the expiration date of the licence. The case will hinge on the discretionary actions of THE MINISTER since the application was made, actions that have undermined the companies ability to fund and progress work required to declare the discovery commercial and develop the licence. A discovery has been made. The actions of the minister will be proven to be deliberate at worst or negligent at best.
The lack of engagement over recent weeks is a continuation of the ministers dismissive attitude towards logp and bey legitimate claims. The paper trail is in place. His ideology will count for nothing when the legal hounds clamp their jaws on his green and red gentleman vegetables... if he has any.
Obviously an expert in dicktion....
Ha ha...derived from proverbs 21v20 thats starts
'There is treasure to be desired and oil in the dwelling of the wise'
Mamms,
so you are saying its an even money bet, lets say a coin toss, but you have found a bookmaker willing to pay odds of 10 or 20-1. .....on a coin toss??????
Thanks for convincing me that its worth a punt.
I am in for 1%.
50% = 10 or 20-1????
wow.
Longerwait ,
if drilling is risky then why is ryan putting out videos about geothermal?
I tell you why. Because his issue is not the risks and high costs associated with drilling. He has decided that hydro carbons are evil.
That is it....nothing else.
He conveniently ignores that his daily life is dependant on hydro carbons, as is yours.
If it was not for hydrocarbons the very device you are using to post anti logp messages would not exist.
My recommendation would be that anyone that is genuinely against the use of hydrocarbons for plastics, energy and chemicals- stop using your devices, stop taking energy from the grid and live in a cave or build your own wooden shack off the grid in isolation from the rest of society, get rid of your car, grow your own food, heat your own home in winter, make your own clothes and medicines.
If you arent willing to do that then shut the f up.
Unfortunately, this reluctance to engage in dialogue and rational debate is typical of those that share the ideology of ryan. That is why the transition to green energy has been such a disaster. Decisions are not based on data, logic or truth. Instead, phrases like ' our planet is burning' are used to legitimise idiocy. We are descending into madness on so many fronts where a small minded minority are being allowed to destroy everything that we hold dear. How did we let this happen? The backlash is coming down the tracks. I hope its a KO.
The 5m from stalicla is not within their control.
It is dependant on when stalicla submit the IND.
The part that was within their control was the ph1 completion and they achieved that.
They are anticipating the IND submission and the payment associated with it b4 the money runs out but how can they give a definite date. It is up to stalicla.
Are you saying if that 5m is received that will take them forward another 18 months beyond their current date of q4 2024. ....just for future ref.
'$0.5m upfront, $0.5m on completion of the, already fully financed, Evgen-sponsored human volunteer Phase 1 study (anticipated during Q2 2023). Milestone payments up to commercial launch are $26.5m, including $5m on grant of IND by the FDA (anticipated in late 2023). '
So $0.5m due now.
The stalicla website still indicates that PH2 trials for STP 2 is planned to start late 23 and they will need to submit the IND 30 days b4 that can start.
Receipt of that cash is down to stalicla progress so defo
worth keeping an eye on their developments for STP2.
Once we have multiple trials in Phase II( especially if evgen manage to secure another licence deal ) then think we are a target. IMO.
CJ39.
Your whole argument rests on whether further dilution is imminent.
Do you know what the next steps are with stalicla and what this means for evgen?
for eg. how much do evgen get when stalicla get the IND?
As far as I am aware, SFX-01 is the only stabilised sulforaphane suitable for clinical research and eventual approval as a medicine.
This latest Phase 1 news should not be taken lightly.
It doesnt have to be a 'cure'.
Improving quality of life by alleviating symptoms or enhancing the effectiveness of existing treatments would make SFX01 extremely valuable.
The use of sulforaphane to help alleviate the symptoms of autism has already been trialled. Do you have google?
Why do you think stalicla selected it as the most suitable candidate for STP2? Do you think they have just decided to 'give it a go' ?
I wonder why I have been told to take painkillers for my dodgy tooth? Surely that isnt 'curing' my tooth. Painkillers musnt make any money for pharma companies.
...is 18/19 sept.
Thats uncomfortably close to the 3 month deadline.
Ryan is no doubt very proud of his involvement.
Hubris comes before Nemesis.
It is going to be a joy to behold.
...boldy
sorry steve.
got you mixed up with the ****nal ( and sunderland - ftm) defender.
I think he was referring to the multiple target zones.
see images in following report.
https://www.offshore-technology.com/projects/barryroe-oil-field-north-celtic-sea-basin/
I dont think he was referring to unexpected compartmentalisation that Steve Remp (RIP) discovered with ramco on seven heads.
The appraisal drilling would have helped assess that risk.
I just want compensation now. TBH I think that Steve Bouldy will be relieved to end his relationship with providence / exola / barryroe or whatever they call themselves now.
How do you know its compartmentalised?
Sulforaphane is a naturally occurring compound so a lot of the safety risk is removed.
SFX01 is just a stabilised form of sulforaphane.
One of the underlying conditions associated with ASD is oxidative stress.
Sulforaphane helps with this.
Stalicla have studied the biology and are developing STP 2( their name for SFX01) specifically to help those for whom oxidative stress is an underlying factor in ASD.
IMO this is a winner but time will tell.
So it isnt 1 in 99 then.
What are the odds from phase II onwards?
The phase I risk needs removing from the overall for the ASD trial.
Having said that, king alf has a better chance of being able to say 'I told you all it would not work' than evgen/ stailcla have of succeeding. IMO its slightly better than a dice roll ATM from start of phase II to full approval.
However, this is going to be a test of stalicla' s targetted selection method. Pfizer have dramatically improved their POS in phase II over the competiton in recent years. Stalicla are hoping their selection method will improve POS even more.
My hope is that with the multiple uses being in the evgen pipeline (that reduces overall risk) and the oodles of cash available to big pharma at the mo for M&A , that evgen get acquired by someone willing to take on the risk.
The more options we can get into Phase II ASAP the better.